EGFR and neoplasm: This study attempted to determine the impacts of IL-17A on EGFR-mediated tumor proliferation and responses to EGFR-TKI treatment in LUAD, and to further investigate the mechanisms involved in the crosstalk between IL-17A and EGFR signaling.